The PMPRB will hold a public Hearing into the Price of Tactuo

OTTAWA, October 1, 2012 – The Patented Medicine Prices Review Board will hold a public hearing in the Standard Life Centre, 18th Floor, 333 Laurier Avenue W, Ottawa, Ontario, on a date to be determined by the Hearing Panel on November 13, 2012, or shortly thereafter.

The purpose of the hearing is to determine whether, under sections 83 and 85 of the Patent Act, Galderma Canada Inc. is selling or has sold the medicine known as Tactuo in any market in Canada at a price that, in the Board's opinion, is or was excessive and if so, what order, if any, should be made.

Tactuo is indicated for the treatment of acne.

Persons wishing to intervene in this proceeding are required to apply to the Board for leave to intervene. Such persons should contact the Secretary of the Board for further information on the procedure.

The Notice of Hearing in this matter and the abridged Statement of Allegations of Board Staff are available on the PMPRB Web site under Hearings and Decisions; Tactuo.

All requests for information on this matter should be addressed to the Secretary of the Board.

The Secretary of the Patented Medicine Prices Review Board
Standard Life Centre
333 Laurier Avenue West
Suite 1400
Ottawa, Ontario
K1P 1C1

Toll-free number: 1-877-861-2350
Direct line: 613-954-8299
TTY: 613-957-4373
Fax: 613-952-7626

Date modified: